scholarly article | Q13442814 |
P6179 | Dimensions Publication ID | 1023522266 |
P356 | DOI | 10.1186/1475-2840-11-86 |
P932 | PMC publication ID | 3461422 |
P698 | PubMed publication ID | 22828168 |
P5875 | ResearchGate publication ID | 230564520 |
P2093 | author name string | Francisco J Tinahones | |
Badimon Lina | |||
Bernal-Lopez M Rosa | |||
Calleja Fernando | |||
Gomez-Carrillo Victor | |||
Gomez-Huelgas Ricardo | |||
Llorente-Cortes Vicenta | |||
Lopez-Carmona Dolores | |||
P2860 | cites work | Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group | Q27860882 |
Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group | Q29547282 | ||
TLR4 links innate immunity and fatty acid-induced insulin resistance | Q29617577 | ||
Progress and challenges in translating the biology of atherosclerosis | Q29619982 | ||
Increased expression of a scavenger receptor (CD36) in monocytes from subjects with Type 2 diabetes | Q30891442 | ||
Oxidative stress is associated with impaired arterial elasticity | Q33760960 | ||
Effects of disturbed flow on vascular endothelium: pathophysiological basis and clinical perspectives | Q34159834 | ||
Association of ADIPOR2 gene variants with cardiovascular disease and type 2 diabetes risk in individuals with impaired glucose tolerance: the Finnish Diabetes Prevention Study | Q35389741 | ||
Increased nitric oxide availability attenuates high fat diet metabolic alterations and gene expression associated with insulin resistance | Q35540671 | ||
Up-regulation of tissue factor in human pulmonary artery endothelial cells after ultrafine particle exposure | Q35752422 | ||
Nuclear factor-kappaB: activation and regulation during toll-like receptor signaling. | Q36755963 | ||
Possible involvement of Cyclic-GMP-dependent protein kinase on matrix metalloproteinase-2 expression in rat aortic smooth muscle cells | Q36783935 | ||
Matrix metalloproteinases: useful and deleterious | Q36883870 | ||
Down-regulation of hepatic HNF4alpha gene expression during hyperinsulinemia via SREBPs | Q37155389 | ||
AMPK and vasculoprotection | Q37812782 | ||
Necrotic cell death in atherosclerosis. | Q37879605 | ||
Diabetic cardiovascular disease--AMP-activated protein kinase (AMPK) as a therapeutic target | Q38013204 | ||
LDL receptor-related protein mediates uptake of aggregated LDL in human vascular smooth muscle cells. | Q38311535 | ||
Simvastatin inhibits cell cycle progression in glucose-stimulated proliferation of aortic vascular smooth muscle cells by up-regulating cyclin dependent kinase inhibitors and p53. | Q39937824 | ||
Hypercoagulability in venous and arterial thrombosis | Q41431413 | ||
Global gene expression profiling displays a network of dysregulated genes in non-atherosclerotic arterial tissue from patients with type 2 diabetes | Q42153827 | ||
Expression of LDL receptor, VLDL receptor, LDL receptor-related protein, and scavenger receptor in rabbit atherosclerotic lesions: marked induction of scavenger receptor and VLDL receptor expression during lesion development | Q42453290 | ||
Overproduction of cyclo-oxygenase-2 (COX-2) is involved in the resistance to apoptosis in vascular smooth muscle cells from diabetic patients: a link between inflammation and apoptosis | Q42478535 | ||
Plaque rupture is a determinant of vascular events in carotid artery atherosclerotic disease: involvement of matrix metalloproteinases 2 and 9. | Q42790003 | ||
Oxidized LDL differentially regulates MMP-1 and TIMP-1 expression in vascular endothelial cells | Q43614849 | ||
Low-density lipoprotein upregulates low-density lipoprotein receptor-related protein expression in vascular smooth muscle cells: possible involvement of sterol regulatory element binding protein-2-dependent mechanism | Q44243303 | ||
Modulation of human monocyte CD36 by type 2 diabetes mellitus and other atherosclerotic risk factors | Q45156504 | ||
Prediction of the risk of cardiovascular mortality using a score that includes glucose as a risk factor. The DECODE Study | Q45232445 | ||
Angiotensin II upregulates LDL receptor-related protein (LRP1) expression in the vascular wall: a new pro-atherogenic mechanism of hypertension | Q46748422 | ||
Intracellular lipid accumulation, low-density lipoprotein receptor-related protein expression, and cell survival in vascular smooth muscle cells derived from normal and atherosclerotic human coronaries | Q47940260 | ||
Intensive glycemic control in the ACCORD and ADVANCE trials | Q53654194 | ||
[Release of nitric oxide induced by blood flow. Update and perspectives of research] | Q74135559 | ||
Pioglitazone inhibits connective tissue growth factor expression in advanced atherosclerotic plaques in low-density lipoprotein receptor-deficient mice | Q80092264 | ||
Matrix metalloproteinase-9 polymorphism contributes to blood pressure and arterial stiffness in essential hypertension | Q80506431 | ||
P407 | language of work or name | English | Q1860 |
P921 | main subject | metabolic pathway | Q68685 |
biomarker | Q864574 | ||
type 2 diabetes | Q3025883 | ||
P304 | page(s) | 86 | |
P577 | publication date | 2012-07-24 | |
P1433 | published in | Cardiovascular Diabetology | Q2468083 |
P1476 | title | Alterations of specific biomarkers of metabolic pathways in vascular tree from patients with Type 2 diabetes | |
P478 | volume | 11 |
Q34503055 | Association of impaired fasting glucose, diabetes and their management with the presentation and outcome of peripheral artery disease: a cohort study |
Q58614010 | MicroRNA profiling of diabetic atherosclerosis in a rat model |
Q55089831 | MicroRNA-146b-3p regulates the development and progression of cerebral infarction with diabetes through RAF1/P38MAPK/COX-2 signaling pathway. |
Q38688810 | P2X7 receptor antagonism modulates IL-1β and MMP9 in human atherosclerotic vessels |
Search more.